8.7
Excellent
376 reviews
- Communication
- 8.8
- Timeliness
- 8.9
- Accuracy
- 7.6
- Staff
- 8.8
- Value
- 8.9
Jaime Schmitt
6.3
- - Stability Studies
- - 16 months July 2023 - November 2024
- - Pharmaceutical Company
Reviewed:
Stability studies lacked detail, required additional validation.
The stability studies conducted were lacking in detail, and we had to perform additional validation to ensure the results were reliable. This added extra time and cost to the project. The team was responsive to feedback, but the initial work was subpar.
Ms. Eileen Larson
9
- - Biomarker Development
- - 12 weeks October 2023 - January 2024
- - Research Institution
Reviewed:
Efficient and precise biomarker development.
The biomarker development project was managed efficiently, with precise results that met our project objectives. The team's expertise in biomarker research was invaluable, and we were impressed with the quality of the deliverables.
Dr. Dustin Sporer
9.3
- - Project Management
- - 10 weeks July - September 2023
- - Biotech Company
Reviewed:
Seamless project management, results exceeded expectations.
Project management was seamless, and the team exceeded our expectations. They handled all aspects of the project with professionalism and efficiency, keeping us informed every step of the way.
Alexandra Rath
8.6
- - Patient Engagement
- - 8 weeks August - September 2023
- - Clinical Research Organization
Reviewed:
Impressive patient engagement strategies, significant improvement in recruitment rates.
The patient engagement strategies implemented were impressive and led to a significant improvement in our recruitment rates. The team's experience in patient-centered approaches was evident and made a real difference.
Rene Kuhn
8.8
- - Companion Diagnostics Development
- - 16 weeks January - May 2024
- - Pharmaceutical Company
Reviewed:
High-quality companion diagnostics development, delivered on time.
The development of companion diagnostics was of high quality, and the project was delivered on time. The team's technical expertise and understanding of the regulatory environment were key to the success of the project.
Cameron Howe
9.5
- - Gene Therapy Development
- - 12 weeks January - March 2023
- - Research Institution
Reviewed:
Innovative approach to gene therapy development, collaborative team.
The gene therapy project was managed exceptionally well, with innovative solutions provided at every stage. The team was highly collaborative and receptive to feedback, making it a truly joint effort. The results exceeded expectations.
